P-ISSN 2587-2400 | E-ISSN 2587-196X
EJMO Volume : 4 Issue : 3 Year : 2020
Eurasian Journal of Medicine and Oncology

* Scientific contribution to the literature on COVID-19 is valuable

Articles in EJMO about COVID-19

EDITORIAL
Successful Treatment Strategy of Turkey against Covid-19 Outbreak
Hilmi Kodaz
doi: 10.14744/ejmo.2020.12345   Pages  177 -  178 


REVIEW
2019 Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature
Ahmet Riza Sahin, Aysegul Erdogan, Pelin Mutlu Agaoglu, Yeliz Dineri, Ahmet Yusuf Cakirci, Mahmut Egemen Senel, Ramazan Azim Okyay, Ali Muhittin Tasdogan
doi: 10.14744/ejmo.2020.12220   Pages  1 -  7 


How to Face with Minimally Invasive Abdominal Surgery During Covid-19 Outbreak? Surgical and Anesthesiological Concerns
Mirko Barone, Marco Prioletta, Luigi Guetti, Sonia Capone, Larissa Pereira Ghammachi, Massimo Ippoliti, Elena Carluccio, Massimo Cieri, Alessandro Marolla, Giuseppe Cipollone, Liberato Aceto, Ivan Dell Atti, Carmine Lanci Lanci, Salvatore Maurizio Maggiore, Felice Mucilli
doi: 10.14744/ejmo.2020.22984

LETTER TO THE EDITOR
COVID-19 Outbreak: How to Use Current Knowledge to better Treat Positive Patients
Massimo Bonucci
doi: 10.14744/ejmo.2020.40842

A Response to Massimo Bonucci’s Editorial: COVID-19 Outbreak: How to Use Current Knowledge to Better Treat Positive Patients
Leung Ping-chung
doi: 10.14744/ejmo.2020.46269

RESEARCH ARTICLE
The Molecular Docking Study of Potential Drug Candidates Showing Anti-COVID-19 Activity by Exploring of Therapeutic Targets of SARS-CoV-2
Rohan R. Narkhede, Rameshwar S. Cheke, Jaya P Ambhore, Sachin D. Shinde
doi: 10.14744/ejmo.2020.31503

IN Silico Approach of Some Selected Honey Constituents as SARS-CoV-2 Main Protease (COVID-19) Inhibitors
Heba E. Hashem
doi: 10.14744/ejmo.2020.36102


REVIEW
Corona Virus: A Review of COVID-19
Dharmendra Kumar, Rishabha Malviya, Pramod Kumar Sharma
doi: 10.14744/ejmo.2020.51418   Pages  8 -  25 


Genome Organization of Covid-19 and Emerging Severe Acute Respiratory Syndrome Covid-19 Outbreak: A Pandemic
Hanuman Singh Dagur, Saurabh Dhakar
doi: 10.14744/ejmo.2020.96781   Pages  107 -  115 


RESEARCH ARTICLE
Case Fatality Rate estimation of COVID-19 for European Countries: Turkey’s Current Scenario Amidst a Global Pandemic; Comparison of Outbreakswith European Countries
Fadime Oztoprak, Aadil Javed
doi: 10.14744/ejmo.2020.60998   Pages  149 -  159 


Modeling and Forecasting for the number of cases of the COVID-19 pandemic with the Curve Estimation Models, the Box-Jenkins and Exponential Smoothing Methods
Harun Yonar, Aynur Yonar, Mustafa Agah Tekindal, Melike Tekindal
doi: 10.14744/ejmo.2020.28273   Pages  160 -  165 


The Impacts of Covariates on Spatial Distribution of Corona Virus 2019 (COVID-19): What Do the Data Show through ANCOVA and MANCOVA?
Habte Tadesse Likassa
doi: 10.14744/ejmo.2019.81104   Pages  141 -  148 


REVIEW
A Review of COVID-19 (Coronavirus Disease-2019) Diagnosis, Treatments and Prevention
Shmmon Ahmad, Abdul Hafeez, Sameera Ali Siddqui, Mumtaz Ahmad, Shruti Mishra
doi: 10.14744/ejmo.2020.90853   Pages  116 -  125 


The Rise of New Coronavirus Infection-(COVID-19): A Recent Update
Suraj N. Mali, Amit P. Pratap, Bapu R. Thorat
doi: 10.14744/ejmo.2020.22222   Pages  35 -  41 


LETTER TO THE EDITOR
Double Trouble: Challenges of Cancer Care in the Philippines during the COVID-19 Pandemic
Frederic Ivan L. Ting, Gracieux Y. Fernando
doi: 10.14744/ejmo.2020.46287   Pages  135 -  136 


Cytokine-targeted therapy in severely ill COVID-19 patients: Options and cautions
Marveh Rahmati, Mohammad Amin Moosavi
doi: 10.14744/ejmo.2020.72142   Pages  179 -  181 


ACE 2 in the Context of COVID 19 – An Opportunity for us or the Virus
Oliyath Ali, Ishrit Yasin
doi: 10.14744/ejmo.2020.87844   Pages  137 -  138 


Recombinant Human Angiotensin-Converting Enzyme 2 and COVID-19 Acute Respiratory Distress Syndrome: A Theoretical or a Real Resource?
Mirko Barone, Claudio Ucciferri, Giuseppe Cipollone, Felice Mucilli
doi: 10.14744/ejmo.2020.47992   Pages  139 -  140 


Pneumocystis Jiroveci Mimicking COVID-19 Pneumonia in a Patient who Receiving Ipilimumab and Nivolumab Combination Therapy: A Case Report
Elissar Moujaess, Elias El Haddad, Joseph Kattan
doi: 10.14744/ejmo.2020.89845

Why are Children Less Affected by COVID-19 ? Could there be an Overlooked Bacterial Co-Infection?
Ramazan Azim Okyay, Ahmet Riza Sahin, Rene A. Aguinada, Muhittin Tasdogan
doi: 10.14744/ejmo.2020.40743   Pages  104 -  105 


REVIEW
How to Face with Minimally Invasive Abdominal Surgery During Covid-19 Outbreak? Surgical and Anesthesiological Concerns
Mirko Barone, Marco Prioletta, Luigi Guetti, Sonia Capone, Larissa Pereira Ghammachi, Massimo Ippoliti, Elena Carluccio, Massimo Cieri, Alessandro Marolla, Giuseppe Cipollone, Liberato Aceto, Ivan Dell Atti, Carmine Lanci Lanci, Salvatore Maurizio Maggiore, Felice Mucilli
doi: 10.14744/ejmo.2020.22984   Pages  181 -  184 
(Viewed: 1304 / Downloaded: 578)

RESEARCH ARTICLE
The Molecular Docking Study of Potential Drug Candidates Showing Anti-COVID-19 Activity by Exploring of Therapeutic Targets of SARS-CoV-2
Rohan R. Narkhede, Rameshwar S. Cheke, Jaya P Ambhore, Sachin D. Shinde
doi: 10.14744/ejmo.2020.31503   Pages  185 -  195 
(Viewed: 1325 / Downloaded: 736)

Epitope-Based Vaccine Design against Novel Coronavirus SARS-CoV-2 Envelope Protein
Hanuman Singh Dagur, Saurabh Singh Dhakar, Apporva Gupta
doi: 10.14744/ejmo.2020.01978   Pages  201 -  208 
(Viewed: 599 / Downloaded: 316)

Hydroxychloroquine as Potent Inhibitor of COVID -19 Main Protease: Grid Based Docking Approach
Jitender Kumar Malik, Himesh Soni, Sarvesh Sharma, Satish Sarankar
doi: 10.14744/ejmo.2020.91607   Pages  219 -  226 
(Viewed: 191 / Downloaded: 220)

Bioinformatics Approach for COVID-19 (Coronavirus) Disease Prevention Treatment and Drug Validation
Shruti Mishra, Prashant Ankur Jain, Shmmon Ahmad, Shivam Mishra
doi: 10.14744/ejmo.2020.97358   Pages  234 -  238 
(Viewed: 240 / Downloaded: 157)

CASE REPORT
Pneumocystis Jiroveci Mimicking COVID-19 Pneumonia in a Patient who is Receiving Ipilimumab and Nivolumab Combination Therapy: A Case Report
Elissar Moujaess, Elias El Haddad, Joseph Kattan
doi: 10.14744/ejmo.2020.89845   Pages  246 -  250 
(Viewed: 817 / Downloaded: 370)

LETTER TO THE EDITOR
COVID-19 Outbreak: How to Use Current Knowledge to better Treat Positive Patients
Massimo Bonucci
doi: 10.14744/ejmo.2020.40842   Pages  251 -  252 
(Viewed: 1443 / Downloaded: 839)

A Response to Massimo Bonucci’s Editorial: COVID-19 Outbreak: How to Use Current Knowledge to Better Treat Positive Patients
Leung Ping-chung
doi: 10.14744/ejmo.2020.46269   Pages  253 -  255 
(Viewed: 239 / Downloaded: 137)

Novel Coronavirus Disease (COVID-19): World’s Past Experience on Deadly Outbreaks
Temesgen A. Gelaw, Biniam M. Eskeziaw, Awoke Y. Dagnaw, Abeba H. Mariamenatu, Abreham C. Alemu, Gebiru S. Wondie, Meskerem K. Meles
doi: 10.14744/ejmo.2020.93695   Pages  256 -  259 
(Viewed: 199 / Downloaded: 138)

COVID-19 Imaging in a Tertiary Care Setting – The Zurich Approach
Victor Mergen, Annelies Zinkernagel, Dagmar I. Keller, Thomas Frauenfelder, Hatem Alkadhi, Andreas Boss
doi: 10.14744/ejmo.2020.68370   Pages  260 -  263 
(Viewed: 223 / Downloaded: 138)
Ejmo Scholarone
We humbly apologize to inform you that due to high intensity, we're not be able to accept review articles about COVID-19.
EJMO Citations
EJMO: Scholarship
Number of Citations: 358
Number of Articles: 201
Accept Ratio : 29.4 %

EJMO NLM ID: 101720527

Our Other Journal EJMI
EJMO & EJMO